Chest pain
- Initial troponin ***
	- Continue to trend troponins to peak every 1-3 hrs for hsTn (3-6 hrs if conventional troponin assays)
- ECG: ***
	- If nondiagnostic, consider serial ECGs to detect potential ischemic changes including if CP recurs or clinical deterioration
- CXR to r/o other potential cardiac, pulmonary, and thoracic causes
- Optimize GDMT/anti-anginal therapy (if known CAD)
- Work-up to exclude other causes of CP

Chest Pain

Schema source

  • Description of chest pain can be helpful1
    • Anginal symptoms gradually build in intensity over a few minutes.
    • Triggers
      • physical exercise
      • emotional stress
    • Associated symptoms include dyspnea, palpitations, diaphoresis, lightheadedness, presyncope or syncope, upper abdominal pain, or heartburn unrelated to meals and nausea or vomiting 1
    • ⚠️ Relief with nitroglycerin is not necessarily diagnostic of myocardial ischemia and should not be used as a diagnostic criterion.
  • Differential diagnosis
    • Sharp chest pain that increases with inspiration and lying supine is unlikely related to ischemic heart disease (e.g., these symptoms usually occur with acute pericarditis) 1
    • Sudden onset of ripping chest pain (with radiation to the upper or lower back) is unlikely to be anginal and is suspicious of an acute aortic syndrome (e.g., aortic dissection).1
    • Ripping chest pain (“worse chest pain of my life”), especially when sudden in onset and occurring in a hypertensive patient, or with a known bicuspid aortic valve or aortic dilation, is suspicious of an acute aortic syndrome (e.g., aortic dissection).
    • Pain that can be localized to a very limited area and pain radiating to below the umbilicus or hip are unlikely related to myocardial ischemia.1
    • Positional chest pain is usually nonischemic (e.g., musculoskeletal)1
  • Pain, pressure, tightness, or discomfort in the chest, shoulders, arms, neck, back, upper abdomen, or jaw, as well as shortness of breath and fatigue should all be considered anginal equivalents.1
  • ⚠️ Avoid the term ‘atypical chest pain’. Instead, use “cardiac,” “possible cardiac,” and “noncardiac” to describe the suspected cause of chest pain1
  • Anginal equivalents (e.g., new-onset/↑ DOE, nausea/vomiting, diaphoresis, unexplained fatigue, or syncope) may occur in those who are…
    • older (e.g., ≥75 years of age)
    • female
    • diabetes mellitus
    • renal dysfunction
    • dementia

Figure source: 2

Non-cardiac causes of chest pain

  • Respiratory
    • Pulmonary Embolism
    • Pneumothorax/hemothorax
    • Pneumomediastinum
    • Pneumonia
    • Bronchitis
    • Pleural irritation
    • Malignancy
  • GI
    • Cholecystitis
    • Pancreatitis
    • Hiatal hernia
    • Gastroesophageal reflux disease/gastritis/esophagitis
    • Peptic ulcer disease
    • Esophageal spasm
    • Dyspepsia
  • MSK
    • Costochondritis
    • Chest wall trauma or inflammation
    • Herpes zoster (shingles)
    • Cervical radiculopathy
    • Breast disease
    • Rib fracture
    • Musculoskeletal injury/spasm
  • Pain disorder
    • Panic disorder
    • Anxiety
    • Clinical depression
    • Somatization disorder
    • Hypochondria
  • Other
    • Hyperventilation syndrome
    • Carbon monoxide poisoning
    • Sarcoidosis
    • Lead poisoning
    • Prolapsed intervertebral disc
    • Thoracic outlet syndrome
    • Adverse effect of certain medications (e.g., 5-fluorouracil)
    • Sickle cell crisis

Unstable angina

ClassPresentation
Rest anginaAngina occuring at rest and prolonged, usually > 20 minutes.
New-onset anginaNew-onset angina of at least CCS class III severity.
Increasing anginaPreviously diagnosed angina that has become distinctly more frequent, longer duration, or lower in threshold (i.e., increased by 1 or more CCS class to at least CCS class III severity)

Risk Scores for Patient Stratification

  • Clinical Decision Pathways are useful to identify low risk patients for early discharge
    • Serial troponins in HEART Pathway, EDACS, ADAPT, etc
    • For example, if HEART score < 3 and normal evaluation patient may be able to be discharged and have outpatient eval.
HEART PathwayEDACSADAPT (mADAPT)NOTR2020 ESC/hs-cTn2016 ESC/GRACE
Target populationSuspected ACSSuspected ACS, CP >5 min, planned serial troponinSuspected ACS, CP >5 min, planned observationSuspected ACS, ECG, troponin orderedSuspected ACS, stableSuspected ACS, planned serial troponin
Target outcome↑ ED discharge without increasing missed 30-d or 1-y MACE↑ ED discharge rate without increasing missed 30-d MACE↑ ED discharge rate without increasing missed 30-d MACE↑ Low-risk classification without increasing missed 30-d MACEEarly detection of AMI; 30-d MACEEarly detection of AMI
Patients with primary outcome in study population, %6–2212155–89.810–17
TroponincTn, hs-cTnhs-cTncTn, hs-cTncTn, hs-cTnhs-cTncTn, hs-cTn
Variables usedHistory
ECG
Age
Risk factors
Troponin (0, 3 h)
Age
Sex
Risk factors
History
Troponin (0, 2 h)
TIMI score 0-1
No ischemic ECG changes
Troponin (0, 2 h)
Age
Risk factors
Previous AMI or CAD
Troponin (0, 2 h)
History
ECG
hs-cTn (0, 1 or 2 h)
Age
HR, SBP
Serum Cr
Cardiac arrest
ECG
Cardiac biomarker
Killip class
![[Acute Coronary Syndromes (ACS)-20240923121531173.webp758]]

HEART Score

  • Helps determine who will benefit from hospital 🏥 admission
  • Low (0-3), Medium (4-6), or High (7-10) Risk for 30-Day MACE

Cardiac Testing

Test selection should be based on patient risk and pre-test likelihood of CAD and may be influenced by site expertise and availability1

1 recommends using clinical decision pathways (CDPs) to categorize patients into low-, intermediate-, and high-risk.

Intermediate-risk Patients

Intermediate Risk and no known CAD

Figure source: Figure 9 of 1

Intermediate Risk with known CAD

  • High-risk CAD features include:
    • left main disease
    • proximal LAD disease
    • multivessel CAD
  • Class 1 indication for invasive coronary angiography for a patient with intermediate-risk p/w acute chest pain with high-risk CAD. Figure source: Figure 10 of 1

Selection of Stress Imaging versus CCTA

Footnotes

  1. Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain. Journal of the American College of Cardiology. 2021;78(22):e187-e285. doi:10.1016/j.jacc.2021.07.053 2 3 4 5 6 7 8 9 10 11 12

  2. Twerenbold R, Boeddinghaus J, Nestelberger T, Wildi K, Rubini Gimenez M, Badertscher P, Mueller C. Clinical Use of High-Sensitivity Cardiac Troponin in Patients With Suspected Myocardial Infarction. J Am Coll Cardiol. 2017 Aug 22;70(8):996-1012. doi: 10.1016/j.jacc.2017.07.718. PMID: 28818210.